Elevated METTL17 expression in AML cells leads to increased OXPHOS activity, shifting metabolism from glycolysis to oxidative phosphorylation, therefore satisfying the high energy demands of proliferating leukemic cells. The gene discussed is METTL17; the disease is acute myeloid leukemia.